Hepatotoxicity, a global problem with local features: toward the creation of a Pan-American Hepatotoxicity Network

被引:9
作者
Isabel Lucena, Maria [1 ,2 ]
Cohen, Henry [3 ]
Hernandez, Nelia [3 ]
Bessone, Fernando [4 ]
Dacoll, Cristina [3 ]
Stephens, Camilla [1 ,2 ]
Borraz, Yolanda [1 ,2 ]
Ulzurrun, Eugenia [1 ,2 ]
Bruguera, Miguel [5 ]
Andrade, Raul J. [1 ,2 ]
机构
[1] Univ Malaga, Hosp Univ Virgen Victoria, Fac Med, Serv Farmacol Clin, E-29071 Malaga, Spain
[2] Univ Malaga, Hosp Univ Virgen Victoria, Fac Med, Unidad Hepatol, E-29071 Malaga, Spain
[3] Hosp Clin Montevideo, Gastroenterol Clin, Montevideo, Uruguay
[4] Univ Nacl Rosario, Fac Med, Hosp Prov Centenario, Serv Gastroenterol & Hepatol, RA-2000 Rosario, Argentina
[5] Hosp Clin Barcelona, Serv Hepatol, Barcelona, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2011年 / 34卷 / 05期
关键词
Hepatotoxicity; Toxic liver damage; Registry; Spanish Hepatotoxicity Registry; Pan-American; Network; INDUCED LIVER-INJURY; CAUSALITY ASSESSMENT; UNITED-STATES; FAILURE; EXPRESSION; GENOTYPE;
D O I
10.1016/j.gastrohep.2011.01.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Drug-induced liver damage is one of the most complex liver diseases due to its similar presentation to other acute or chronic liver processes, its potential severity and the absence of specific biomarkers to confirm diagnosis, which is based on clinical suspicion and exclusion of alternative causes. Because the drug development process fails to completely screen out hepatotoxic molecules and identify susceptible individuals, postmarketing pharmacovigilance remains essential. Hepatotoxicity registries are the ideal instrument for systematic and continual data collection, using preestablished criteria based on consensus. The present article briefly describes the contributions of the Spanish Hepatotoxicity Registry and those of other international registries. Hopefully, Latin American registries will be incorporated into existing initiatives, which will stimulate research and improve understanding of the complex mechanisms involved in this adverse reaction. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 36 条
[1]   Important Elements for the Diagnosis of Drug-Induced Liver Injury [J].
Agarwal, Vijay K. ;
McHutchison, John G. ;
Hoofnagle, Jay H. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (05) :463-470
[2]  
Andrade R J, 2001, Gastroenterol Hepatol, V24, P250
[3]   Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry [J].
Andrade, Raul J. ;
Lucena, M. Isabel ;
Kaplowitz, Neil ;
Garcia-Munoz, Beatriz ;
Borraz, Yolanda ;
Pachkoria, Ketevan ;
Garcia-Cortes, Miren ;
Fernandez, M. Carmen ;
Pelaez, Gloria ;
Rodrigo, Luis ;
Duran, Jose A. ;
Costa, Joan ;
Planas, Ramon ;
Barriocanal, Anabel ;
Guarner, Carlos ;
Romero-Gomez, Manuel ;
Munoz-Yague, Teresa ;
Salmeron, Javier ;
Hidalgo, Ramon .
HEPATOLOGY, 2006, 44 (06) :1581-1588
[4]   Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist [J].
Andrade, RJ ;
Lucena, MI ;
Martin-Vivaldi, R ;
Fernandez, MC ;
Nogueras, F ;
Pelaez, G ;
Gomez-Outes, A ;
Garcia-Escaño, MD ;
Bellot, V ;
Hervás, A ;
Cárdenas, F ;
Bermudez, F ;
Romero, M ;
Salmeron, J .
JOURNAL OF HEPATOLOGY, 1999, 31 (04) :641-646
[5]   Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[6]   DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE [J].
BAKKE, OM ;
MANOCCHIA, M ;
DEABAJO, F ;
KAITIN, KI ;
LASAGNA, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) :108-117
[7]  
Bessone Fernando, 2010, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V9, P355
[8]   Outcome and prognostic markers in severe drug-induced liver disease [J].
Björnsson, E ;
Olsson, R .
HEPATOLOGY, 2005, 42 (02) :481-489
[9]   Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-induced Liver Injury in the United States [J].
Chalasani, Naga ;
Fontana, Robert J. ;
Bonkovsky, Herbert L. ;
Watkins, Paul B. ;
Davern, Timothy ;
Serrano, Jose ;
Yang, Hongqiu ;
Rochon, James .
GASTROENTEROLOGY, 2008, 135 (06) :1924-1934
[10]  
Contreras J, 2003, REV MED CHILE, V131, P1128